Real-time enrollment status for this aml clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 1:26 AM UTC
| NCT Number | NCT07702578 |
| Recruiting Status | Recruiting |
| Condition | AML |
| Phase | PHASE3 |
| Target Enrollment | 310 participants |
| Active Locations | 26 sites in the US |
| Sponsor | TScan Therapeutics, Inc. |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 30, 2026: Clinical trial NCT07702578 is currently recruiting participants. This phase3 study for aml is actively seeking new participants at 26 locations across the United States. The study is sponsored by TScan Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07702578 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07702578 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.